Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer

Heajin Kim 10/1/24 Heajin Kim 10/1/24

Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer

Read More

Luxa Biotechnology Receives $4 Million Grant for Clinical Trial of Dry AMD Treatment

Mediaspace 5/2/24 Mediaspace 5/2/24

Luxa Biotechnology Receives $4 Million Grant for Clinical Trial of Dry AMD Treatment

Read More

Luxa Biotechnology announces paper on 'Identification of Biomarkers for Diversity and Transplantation Efficacy of Retinal Pigment Epithelial Cells' by Dr. Sally Temple.

Mediaspace 1/23/24 Mediaspace 1/23/24

Luxa Biotechnology announces paper on 'Identification of Biomarkers for Diversity and Transplantation Efficacy of Retinal Pigment Epithelial Cells' by Dr. Sally Temple.

Read More

Luxa Biotechnology to Provide Update on Clinical Trial of Retinal Pigmented Epithelium Stem Cell (RPESC) Technology for Treatment of Dry Age-Related Macular Degeneration in Panel Session at ARVO

Mediaspace 1/23/24 Mediaspace 1/23/24

Luxa Biotechnology to Provide Update on Clinical Trial of Retinal Pigmented Epithelium Stem Cell (RPESC) Technology for Treatment of Dry Age-Related Macular Degeneration in Panel Session at ARVO

Read More

The Report of the Annual Meeting hosted by the National Eye Institute in the United States has been released

Mediaspace 1/23/24 Mediaspace 1/23/24

The Report of the Annual Meeting hosted by the National Eye Institute in the United States has been released

Read More